Hot Topics: Decision making

Blog Posts (4)

October 22, 2018

BioethicsTV (October 15-18) #TheResident, #TheGoodDoctor, #NewAmsterdam, #ChicagoMed

by Craig Klugman, Ph.D.

“Exploring ethical issues in TV medical dramas”

Jump to The Resident (Season 2; Episode 4): Medical Lawsuits; Jump to The Good Doctor (Season 2; Episode 4): Inappropriate coercion to remove autonomy; Jump to New Amsterdam (Season 1; Episode 4): Conflicts of interest; Giving bad news; Jump to Chicago Med (Season 4: Episode 4): When medicine and immigration collide; tough choices

The Resident (Season 2; Episode 4): Medical Lawsuits

This episode is less about particular stories than the about the topic of malpractice lawsuits.…

October 22, 2018

The One Health Approach to Zoonotic Emerging Infectious Diseases

The following post can also be found in the October 2018
issue of the American Journal of Bioethics.

by Ariadne Nichol and David Magnus, Ph.D.

September 21, 2018

We Convey More Than We (Literally) Say

by Jason N. Batten, Bonnie O. Wong, William F. Hanks & David Magnus

This issue of the American Journal of Bioethics features a target article by Blumenthal-Barby and Ubel that focuses on patients who are unrealistically optimistic, in denial, or self-deceived.…

August 24, 2018

Best Interest, Harm, God’s Will, Parental Discretion, or Utility

This post also appears in the August 2018 issue of the American Journal of Bioethics.

by John D. Lantos, Ph.D

The impassioned and well-reasoned essays in this edition of the journal all agree with two claims: (1) children have moral claims that should be protected and recognized, and (2) we need ongoing discussions on how to determine and weigh the interests of children when we make decisions for them.…

Published Articles (5)

American Journal of Bioethics: Volume 18 Issue 9 - Sep 2018

In Defense of “Denial”: Difficulty Knowing When Beliefs Are Unrealistic and Whether Unrealistic Beliefs Are Bad J. S. Blumenthal-Barby & Peter A. Ubel

American Journal of Bioethics: Volume 18 Issue 9 - Sep 2018

We Convey More Than We (Literally) Say Jason N. Batten, Bonnie O. Wong, William F. Hanks & David Magnus

American Journal of Bioethics: Volume 18 Issue 8 - Aug 2018

When Parents Refuse: Resolving Entrenched Disagreements Between Parents and Clinicians in Situations of Uncertainty and Complexity Janine Penfield Winters

American Journal of Bioethics: Volume 18 Issue 8 - Aug 2018

The Harm Principle Cannot Replace the Best Interest Standard: Problems With Using the Harm Principle for Medical Decision Making for Children Johan Christiaan Bester

American Journal of Bioethics: Volume 18 Issue 8 - Aug 2018

Best Interest, Harm, God’s Will, Parental Discretion, or Utility John D. Lantos

News (10)

November 15, 2018 9:00 am

What if the Placebo Effect Isn’t a Trick? (The New York Times)

But as ubiquitous as the phenomenon is, and as plentiful the studies that demonstrate it, the placebo effect has yet to become part of the doctor’s standard armamentarium — and not only because it has a reputation as “fake medicine” doled out by the unscrupulous to the credulous. It also has, so far, resisted a full understanding, its mechanisms shrouded in mystery. Without a clear knowledge of how it works, doctors can’t know when to deploy it, or how.

November 14, 2018 9:00 am

F.D.A. Plans to Seek a Ban on Menthol Cigarettes (The New York Times)

In a landmark move bound to further shake the tobacco industry, the Food and Drug Administration plans to propose a ban on menthol cigarettes next week as part of its aggressive campaign against flavored e-cigarettes and some tobacco products, agency officials said.

November 12, 2018 9:00 am

A systematic literature review of individuals’ perspectives on privacy and genetic information in the United States (PLOS)

The picture of genetic privacy that emerges from this systematic literature review is complex and riddled with gaps. When asked specifically “are you worried about genetic privacy,” the general public, patients, and professionals frequently said yes. In many cases, however, that question was posed poorly or only in the most general terms. While many participants expressed concern that genomic and medical information would be revealed to others, respondents frequently seemed to conflate privacy, confidentiality, control, and security. People varied widely in how much control they wanted over the use of data.

November 9, 2018 1:00 pm

23andMe’s genetic test for how you’ll react to medication is ahead of its time (The Verge)

The doctor still isn’t supposed to suggest changing medication until they have you genetically tested again by an independent lab. “It seems to me that if a patient has an interest in their pharmacogenetic profile that could impact medication decisions, they’re probably better off just asking the physician about what testing can be done

November 8, 2018 9:00 am

F.D.A. Approves Powerful New Opioid Despite Warnings of Likely Abuse (The New York Times)

The Food and Drug Administration on Friday approved a new form of an extremely potent opioid to manage acute pain in adults, weeks after the chairman of the advisory committee that reviewed it asked the agency to reject it on grounds that it would likely be abused.

October 19, 2018 9:00 am

Why I Wanted to Learn to Perform Abortions (The New York Times)

These personal and medical decisions are difficult enough. Now the specter of legislation is creeping into doctors’ offices and labor and delivery suites. Conversations we should never entertain — ones that start with, “Is she sick enough yet?” — are becoming more common.

October 9, 2018 9:00 am

My child has two parents. Why does day care call only me? (The Washington Post)

A school’s unwillingness to communicate with fathers, while most disruptive to the mothers who end up doing more than their share of the family care work, can affect children, too.

October 2, 2018 3:39 pm

Memorial Sloan Kettering Cancer Center Announces Conflict of Interest Task Force (Memorial Sloan Kettering Cancer Center )

The task force was announced in a statement from MSK President and Chief Executive Officer Craig Thompson, MD. It will be chaired by Debra Berns, MSK’s Senior Vice President and Chief Risk Officer.

September 20, 2018 6:00 am

Are We Being Misled About Precision Medicine? (The New York Times)

Doctors and hospitals love to talk about the cancer patients they’ve saved, and reporters love to write about them. But deaths still vastly outnumber the rare successes.

September 3, 2018 1:21 am

John McCain did not 'lose' his battle with glioblastoma — because cancer is not a war (NBC News)

A little more than one year has passed since John McCain was diagnosed with glioblastoma, an aggressive form of brain cancer that carries a grim prognosis. On Saturday, only one day after it was announced that the Arizona senator had decided to “discontinue medical treatment,” he passed away.